REG - GSK PLC - Board Committee Change

GSKAnnouncement

Today 15:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260309:nRSI8721Va&default-theme=true

RNS Number : 8721V  GSK PLC  09 March 2026

Issued: 9 March 2026, London UK

 

Board Committee Change

 

 

GSK plc today announces the following change to its Board committee membership
with effect from 9 March 2026:

 

Elizabeth McKee Anderson has been appointed as a member of the Corporate
Responsibility Committee. This appointment is in addition to her membership of
the Audit & Risk and Remuneration committees.

 

 

V A Whyte

Company Secretary

 

9 March 2026

 

 

About GSK

GSK is a global biopharma company with a purpose to unite science, technology,
and talent to get ahead of disease together. Find out more at www.gsk.com
(http://www.gsk.com) .

 

Registered in England & Wales:

No. 3888792

 

Registered Office:

79 New Oxford Street

London

WC1A 1DG

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAEANDNELSKEEA



            Copyright 2019 Regulatory News Service, all rights reserved